An estimated 17 million people die each year of cardiovascular diseases, particularly heart attack and stroke each year, but many of these are preventable.
Current diagnostics are either not sufficiently accurate, expensive, or burdensome to the patient. Elucid’s vascuCAP® is the first ever, FDA-approved and CE-marked, accurate, non-invasive image analysis software for evaluating CT images of arterial vessels to asses risk and inform treatment selection.
FDA and CE cleared, patent-protected product that provides best in class flow, infarct risk, and systemic inflammation assessment from a single CTA (non -invasively)
Substantial diagnostic accuracy improvement in both Carotid and Coronary applications, net reclassification of 24% and 41% respectively1 leading to substantial reduction in overtreatment & costs
- Vascular Surgeons
Schedule a Demo Today
Please provide your full name, email, and phone to request a CAP demo